U.S. Congress, Office of Technology Assessment. The continuing challenge of tuberculosis. Washington, DC: U.S. Government Printing Office; 1993.
Braun MM, Byers RH, Heyward WL, et al. Acquired immunodeficiency syndrome and extrapulmonary tuberculosis in the United States. Arch Intern Med. 1990;150:1913-1916.
Braun MM, Cote TR, Robkin CS. Trends in death with tuberculosis during the AIDS era. JAMA. 1993;269(22):2865-2868.
Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144:745-749.
Cantwell MF, Shehab ZM, Costello AM, et al. Congenital tuberculosis. N Engl J Med. 1994;330:1051-1054.
Cantwell MF, Snider DE, Cauthen GM, Onorato I. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994;272(7):535-539.
Chawla PK, Klapper PJ, Kamholz SL, et al. Drug-resistant in an urban population including patients at risk for human immunodeficiency virus infection. Am Rev Respir Dis. 1992;146:280-284.
Fitzgerald JM, Grzybowski S, Allen EA. The impact of human immunodeficiency virus infection on tuberculosis and its control. Chest. 1991;100(1):191-200.
Jereb JA, Kelly GD, Porterfield DS. The epidemiology of tuberculosis in children. Seminars in Pediatr Infect Dis J. 1993;4(4):220-231.
Jereb JA, Kelly GD, Dooley SW, et al. Tuberculosis morbidity in the United States: Final data, 1990. MMWR. 1991;40(SS-3):23-27.
Jones DS, Malecki JM. Bigler WJ, et al. Pediatric tuberculosis and human immunodeficiency virus infection in Palm Beach County, Florida. Am J Dis Child. 1992;146:1166-1170.
Malasky C, Jordan T, Potulski F, et al. Occupational tuberculous infection among pulmonary physicians in training. Am Rev Respir Dis. 1990;142:505-507.
Onorato IM, McCray E. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis. 1992;165:87-92.
Reider HL, Kelly GD, Bloch AB, et al. Tuberculosis diagnosed at death in the United States. Chest. 1991;100:678-681.
Reider HL, Snider DE, Cauthen GM. Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis. 1990;141:347-351.
Snider DE, Seggerson JJ, Hutton MD. Tuberculosis and migrant farm workers. JAMA. 1991-265(13):1732.
Starke JR, Jacobs RF, Jereb J. Resurgence of tuberculosis in children. J Pediatr. 1992;120(6):839-855.
Torres RA, Mani S, Altholz J, et al. Human immunodeficiency virus infection among homeless men in a New York City shelter: association with Mycobacterium tuberculosis infection. Arch Intern Med. 1990;150:2030-2036.
Dannenberg AM. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today. 1991;12(7):228-233.
Edlin BR, Tokars JI, Grieco MH, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992;326:1514-1521.
Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545-550.
Selwyn PA, Sckell BM, Alcabes P, et al. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA. 1992;268(4):504-509.
Graham NMH, Nelson KE, Solomon L, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and seronegative intravenous drug users. JAMA. 1992;267(3);369-373.
Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis. 1993;17; 968-975.
Huebner RE, Villarino ME, Snider DE. Tuberculin skin testing and the HIV epidemic. JAMA. 1992;267(3):409-410.
Rosenberg T, Manfreda J, Hershfield ES. Two-step tuberculin testing in staff and residents of a nursing home. Am Rev Respir Dis. 1993;148:1537-1540.
Brisson-Noel A, Aznar C, Chureau C, et al. Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet. 1991;338:364-366.
Butler WR, Kilburn JO. Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. J Clin Microbiol. 1988;26(1):50-53.
Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphism. N Engl J Med. 1992;326:231-235.
Daniel TM. The rapid diagnosis of tuberculosis: a selective review. J Lab Clin Med. 1990;116(3):277-282.
David HL. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol. 1970;20:810-814.
Eisenach KD, Sifford MD, Cave MD, et al. Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. Am Rev Respir Dis. 1991;144:1160-1163.
Ellner PD, Kiehn TE, Cammarata R, Hosmer M. Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic probe methods. J Clin Microbiol. 1988;26(7):1349-1352.
Heifets LB. Rapid automated methods (BACTEC system) in clinical microbiology. Semin Respir Infect. 1986;1(4):242-249.
Jacobs WR, Barletta RG, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter pages. Science. 1993;260:819-822.
Kramer F, Modilevsky T, Waliany AR, et al. Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med. 1990;89:451-456.
Shankar P, Manjunath N, Lakshmi R, et al. Identification of Mycobacterium tuberculosis by polymerase chain reaction. Lancet. 1990;335:423.
Shoemaker SA, Fisher JH, Jones WD, Scoggin CH. Restriction fragment analysis of chromosomal DNA defines different strains of Mycobacterium tuberculosis. Am Rev Respir Dis. 1986;134:210-213.
Thierry D, Chureau C, Aznar C, et al. The detection of Mycobacterium tuberculosis in uncultured clinical specimens using the polymerase chain reaction and a non-radioactive DNA probe. Mol Cell Probes. 1992;6:181-191.
Wilson SM, McNerney R, Nye PM, Godfrey-Faussett PD, et al. Progress toward a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. J Clin Microbiol. 1993;31(4):776-782.
Bass JB. Tuberculin test, preventive therapy, and elimination of tuberculosis. Am Rev Respir Dis. 1990;141:812-813.
Fitzgerald JM, Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive mantoux skin test. Am Rev Respir Dis. 1990;142:848-853.
Jordan TJ, Lewit EM, Reichman LB. Isoniazid preventive therapy for tuberculosis: Decision analysis considering ethnicity and gender. Am Rev Respir Dis. 1991;144:1357-1360.
Jordan TJ, Lewit EM, Montgomery RL, et al. Isoniazid as preventive therapy in HIV-infected intravenous drug abusers. JAMA. 1991;265(22):2987-2991.
Koplan JP, Farer LS. Choice of preventive treatment for isoniazid-resistant tuberculous infection: Use of decision analysis and the delphi technique. JAMA. 1980;244(24):2736-2740.
Nazar-Stewart V, Nolan CM. Results of a directly observed intermittent isoniazid preventive therapy program in a shelter for homeless men. Am Rev Respir Dis. 1992;146:57-60.
Passanante MR, Restifo RA, Reichman LB. Preventive therapy for the patient with both universal indication and contraindication for isoniazid. Chest. 1993;103:825-831.
Barnes PF, Bloch AB, Davidson PT, et al. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med. 1991;324(23):1644-1650.
Busillo CP, Lessnau KD, Sanjana V. Multidrug resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest. 1992;102:797-801.
Cohn DL, Catlin BJ, Peterson KL, et al. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. Ann Intern Med. 1990;112:407-415.
Combs DL, Geiter LJ, O'Brien RJ. The USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity and acceptability: the report of final results. Ann Intern Med. 1990;112:397-406.
Dooley SW, Jarvis WR, Martone WJ, et al. Multidrug-resistant tuberculosis (Editorial). Ann Intern Med. 1992;117:257-258.
Etkind S, Boutotte J, Ford J, et al. Treating hard-to-treat tuberculosis patients in Massachusetts. Semin Respir Infect. 1991;6(4):273-282.
Fischl MA, Daikos GL, Uttamchandani RB, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med. 1992;117:184-190.
Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993;328(8):521-526.
Glassroth J. Tuberculosis treatment: risk, benefit, and perspective. Chest. 1991;99(2):266-267.
Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328(8):527-532.
Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis: we can't afford not to try it (Editorial). N Engl J Med. 1993;328(8):576-578.
Iseman MD, Madsen LA. Drug-resistant tuberculosis. Clin Chest Med. 1989;10(3):341-353.
Iseman MD, Sbarbaro JA. Short-course chemotherapy of tuberculosis: hail Britannia (and friends)! Am Rev Respir Dis. 1991;143:697-698.
Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA. 1993;270(1)65-68.
Mitchison DA. The Garrod Lecture: understanding the chemotherapy of tuberculosis--current problems. J Antimicrob Chemother. 1992;29:477-493.
Nolan CM. Failure of therapy for tuberculosis in human immunodeficiency virus infection. Am J Med Sci. 1992;304(3):168-173.
Pitchenik AE, Fertel D. Tuberculosis and nontuberculous mycobacterial disease. Med Clin North Am. 1992;76(1):121-171.
Simone PM, Iseman MD. Drug-resistant tuberculosis: A deadly--a growing--danger. J Respir Dis. 1992;13(7):960-971.
Small PM, Schecter GF, Goodman PC, et al. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl Med. 1991;324:289-294.
Snider DE. Pregnancy and tuberculosis. Chest. 1984;86S:10S-13S.
Snider DE, Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis. 1992;145:494-497.
Starke JR. Current chemotherapy for tuberculosis in children. Infect Dis Clin North Am. 1992;6:215-238.
Stead WW, Dutt AK. Tuberculosis in elderly persons. Annu Rev Med. 1991;42:267-276.
Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis. 1993;147:1311-1320.
Theuer CD, Hopewell PC, Elias D, et al. Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis. 1990;162:8-12.
Van Scoy RE, Wilowske CJ. Antituberculous agents. Mayo Clin Proc. 1992;67:179-187.
Villarino ME, Geiter LJ, Simone PM. The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Public Health Rep. 1992;107(6):616-625.
Weis SE, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330:1179-1184.
Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA. 1992;268(10):1280-1286.
Beckman SE, Osterholm MT, Henderson DK. Tuberculosis in the health care setting in the 1990s: from Bird Island to the Bronx. Infect Control Hosp Epidemiol. 1993;14:228-232.
Castro KG, Dooley SW. Mycobacterium tuberculosis transmission in health care settings; is it influenced by coinfection with human immunodeficiency virus? Infect Control Hosp Epidemiol. 1993;14:65-66.
Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991. MMWR. 1991;40:585-591.
Centers for Diseases Control. Outbreak of multidrug-resistant tuberculosis--Texas, California, and Pennsylvania. MMWR. 1990;39:369-372.
Chaisson RE, McAvinue S. Control of tuberculosis during aerosol therapy administration. Respir Car. 1991;36(9):1017-1025.
Dooley SW, Villarino ME, Lawrence M, et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA. 1992;267(19):2632-2635.
Hutton MD, Stead WW, Cauthen GM, et al. Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis. 1990;161:286-295.
Nardell EA. Dodging droplet nuclei: reducing the probability of nosocomial tuberculosis transmission in the AIDS era. Am Rev Respir Dis. 1990;142:501-503.
Pearson ML, Jereb JA, Frieden TR, Crawford, JT, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med. 1992;117(3):191-196.
Bellin EY, Fletcher DD, Safyer SM. Association of tuberculosis infection with increased time in or admission to the New York City jail system. JAMA. 1993;269:(17):2228-2231.
Centers for Disease Control. Prevention and control of tuberculosis in correctional institutions: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR. 1989;38:313-320,325.
Centers for Disease Control. Prevention and control of tuberculosis in facilities providing long-term care to the elderly: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR. 1990;39(RR-10):7-20.
Centers for Disease Control. Prevention and control tuberculosis in migrant farm workers: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR. 1992;41(RR-17):1-14.
Centers for Disease Control. Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. MMWR. 1992;41(RR-5):1-11.
Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional systems--New York, 1991. MMWR. 1992;41:507-509.
Centers for Disease Control. Tuberculosis among foreign-born persons entering the United States: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR. 1990;39(RR-18):1-21.
Centers for Disease Control. Tuberculosis among residents of shelters for the homeless. MMWR. 1991;40(50):869-871.
Centers for Disease Control. Tuberculosis prevention in drug-treatment centers and correctional facilities--selected U.S. sites, 1990-1991. MMWR. 1993;42(RR-11):210-213.
Rubel AJ, Garro LC. Social and cultural factors in the successful control of tuberculosis. Public Health Rep. 1992;107(6):626-636.
Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA. 1994;271:698-702.
Greenberg PD, Lax KG, Schechter CB. Tuberculosis in house staff: a decision analysis comparing the tuberculin strategy with the BCG vaccination. Am Rev Respir Dis. 1991;143:490-495.
Snider DE. Bacille Calmette-Guerin vaccinations and tuberculin skin tests. JAMA. 1985;253(23):3438-3439.